Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GUANFACINE 2 MG TABLET

Gaunfacine
$0.2515per EA

Strength

2 mg/1

Manufacturer

i3 Pharmaceuticals, LLC

NDC

72319001904

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GUANFACINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216828

On Market Since

10/31/2022

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price History

1W

0.0%

1M

+4.0%

3M

-1.6%

6M

-14.5%

1Y

-20.2%

3Y

N/A

5Y

N/A

All

-38.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CLONIDINE HCL 0.1 MG TABLET
Generic
00228212710•Actavis Pharma, Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00228212750•Actavis Pharma, Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00904744261•Major Pharmaceuticals
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046801•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046805•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046810•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056510•Solco Healthcare US LLC
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056511•Solco Healthcare US LLC
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
50268019215•AvPAK
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
52817018000•TruPharma LLC
$0.0247
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy